EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹21 Cr | ₹19 Cr | ₹9.49 Cr | ₹8.03 Cr | ₹0.08 Cr |
What is the latest Capital Work in Progress ratio of EVEREST ORGANICS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹9.49 Cr |
| Mar2022 | ₹8.03 Cr |
| Mar2021 | ₹0.08 Cr |
How is Capital Work in Progress of EVEREST ORGANICS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 10.46 | |
| Mar2024 | ₹19 Cr | 103.86 | |
| Mar2023 | ₹9.49 Cr | 18.18 | |
| Mar2022 | ₹8.03 Cr | 10,606.67 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Capital Work in Progress of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹300.1 Cr | 1.4% | 19.2% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 1.4% |
19.2% |
-12.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses